CLEARPOINT NEURO ($CLPT) posted quarterly earnings results on Tuesday, August 12th. The company reported earnings of -$0.21 per share, missing estimates of -$0.20 by $0.01. The company also reported revenue of $9,215,000, missing estimates of $9,384,000 by $-169,000.
You can see Quiver Quantitative's $CLPT stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
CLEARPOINT NEURO Insider Trading Activity
CLEARPOINT NEURO insiders have traded $CLPT stock on the open market 4 times in the past 6 months. Of those trades, 0 have been purchases and 4 have been sales.
Here’s a breakdown of recent trading of $CLPT stock by insiders over the last 6 months:
- JOSEPH BURNETT (CEO and President) sold 21,247 shares for an estimated $282,372
- TIMOTHY T. RICHARDS sold 10,000 shares for an estimated $132,800
- LYNNETTE C FALLON has made 0 purchases and 2 sales selling 10,200 shares for an estimated $128,226.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
CLEARPOINT NEURO Hedge Fund Activity
We have seen 63 institutional investors add shares of CLEARPOINT NEURO stock to their portfolio, and 45 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BLACKROCK, INC. added 1,323,026 shares (+321.8%) to their portfolio in Q2 2025, for an estimated $15,796,930
- MILLENNIUM MANAGEMENT LLC added 452,043 shares (+156.3%) to their portfolio in Q1 2025, for an estimated $5,374,791
- GEODE CAPITAL MANAGEMENT, LLC added 323,429 shares (+107.3%) to their portfolio in Q2 2025, for an estimated $3,861,742
- INVESCO LTD. removed 247,977 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $2,948,446
- VANGUARD GROUP INC added 191,142 shares (+14.9%) to their portfolio in Q2 2025, for an estimated $2,282,235
- TUDOR INVESTMENT CORP ET AL added 128,698 shares (+inf%) to their portfolio in Q1 2025, for an estimated $1,530,219
- GOLDMAN SACHS GROUP INC added 127,823 shares (+98.3%) to their portfolio in Q1 2025, for an estimated $1,519,815
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
CLEARPOINT NEURO Analyst Ratings
Wall Street analysts have issued reports on $CLPT in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- B. Riley Securities issued a "Buy" rating on 04/25/2025
- Stifel issued a "Buy" rating on 04/01/2025
To track analyst ratings and price targets for CLEARPOINT NEURO, check out Quiver Quantitative's $CLPT forecast page.
CLEARPOINT NEURO Price Targets
Multiple analysts have issued price targets for $CLPT recently. We have seen 2 analysts offer price targets for $CLPT in the last 6 months, with a median target of $26.5.
Here are some recent targets:
- Neil Chatterji from B. Riley Securities set a target price of $28.0 on 04/25/2025
- Mathew Blackman from Stifel set a target price of $25.0 on 04/01/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
